Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53

被引:174
作者
von der Thüsen, JH
van Vlijmen, BJM
Hoeben, RC
Kockx, MM
Havekes, LM
van Berkel, TJC
Biessen, EAL
机构
[1] Leiden Univ, Gorlaeus Labs, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Mol Virol Grp, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[5] TNO, Prevetn & Hlth, PG, Leiden, Netherlands
[6] Middelheim Acad Hosp, Dept Pathol, Antwerp, Belgium
关键词
apoptosis; atherosclerosis; carotid arteries; genes; muscle;
D O I
10.1161/01.CIR.0000015502.97828.93
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The presence of the tumor-suppressor gene p53 in advanced atherosclerotic plaques and the sensitivity to p53-induced cell death of smooth muscle cells isolated from these plaques have fueled speculation about the role of p53 in lesion destabilization and plaque rupture. In this study. we describe a strategy to promote (thrombotic) rupture of preexisting atherosclerotic lesions using p53-induced lesion remodeling. Methods and Results-Carotid atherogenesis was initiated in apolipoprotein E knockout mice by placement of a perivascular silastic collar. The resulting plaques were incubated transluminally with recombinant adenovirus carrying either a p53 or beta-galactosidase (lacZ) transgene. p53 transfection was restricted to the smooth muscle cell-rich cap of the plaque and led to an increase in cap cell apoptosis I day after transfer. p53 overexpression resulted in a marked decrease in the cellular and extracellular content of the cap, reflected by a markedly reduced cap/intima ratio (0.21+/-0.04 versus 0.46+/-0.03. P<0.001). The latter is a characteristic feature of plaque vulnerability to rupture, and whereas spontaneous rupture of p53-treated lesions was rare. it was found in 40% of cases after treatment with the vasopressor compound phenylephrine (P=0.003). Conclusions-We have demonstrated a potential role of p53-induced remodeling in atherosclerotic plaque destabilization. Being the first example of inducible rupture at a predefined location, this model offers a unique opportunity to delineate the processes that precede rupture and to evaluate plaque-stabilizing therapies.
引用
收藏
页码:2064 / 2070
页数:7
相关论文
共 33 条
[1]   BINDING AND PHAGOCYTOSIS OF APOPTOTIC VASCULAR SMOOTH-MUSCLE CELLS IS MEDIATED IN PART BY EXPOSURE OF PHOSPHATIDYLSERINE [J].
BENNETT, MR ;
GIBSON, DF ;
SCHWARTZ, SM ;
TAIT, JF .
CIRCULATION RESEARCH, 1995, 77 (06) :1136-1142
[2]   Apoptosis of vascular smooth muscle cells in atherosclerosis [J].
Bennett, MR ;
Boyle, JJ .
ATHEROSCLEROSIS, 1998, 138 (01) :3-9
[3]   DEREGULATED EXPRESSION OF THE C-MYC ONCOGENE ABOLISHES INHIBITION OF PROLIFERATION OF RAT VASCULAR SMOOTH-MUSCLE CELLS BY SERUM REDUCTION, INTERFERON-GAMMA, HEPARIN, AND CYCLIC-NUCLEOTIDE ANALOGS AND INDUCES APOPTOSIS [J].
BENNETT, MR ;
EVAN, GI ;
NEWBY, AC .
CIRCULATION RESEARCH, 1994, 74 (03) :525-536
[4]   APOPTOSIS OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM NORMAL VESSELS AND CORONARY ATHEROSCLEROTIC PLAQUES [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2266-2274
[5]   Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis [J].
Bennett, MR ;
Littlewood, TD ;
Schwartz, SM ;
Weissberg, PL .
CIRCULATION RESEARCH, 1997, 81 (04) :591-599
[6]  
Bjorkerud S, 1996, AM J PATHOL, V149, P367
[7]   Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice [J].
Calara, F ;
Silvestre, M ;
Casanada, F ;
Yuan, N ;
Napoli, C ;
Palinski, W .
JOURNAL OF PATHOLOGY, 2001, 195 (02) :257-263
[8]  
Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697
[9]  
DRAZAN KE, 1994, SURGERY, V116, P197
[10]   New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses [J].
Fallaux, FJ ;
Bout, A ;
Van der Velde, I ;
Van den Wollenberg, DJM ;
Hehir, KM ;
Keegan, J ;
Auger, C ;
Cramer, SJ ;
Van Ormondt, H ;
Van der Eb, AJ ;
Valerio, D ;
Hoeben, RC .
HUMAN GENE THERAPY, 1998, 9 (13) :1909-1917